share_log

New York City to Pursue Rat Contraception Pilot Program

New York City to Pursue Rat Contraception Pilot Program

紐約市將推進老鼠避孕試點計劃
SenesTech ·  10/08 12:00

PHOENIX, Oct. 8, 2024 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES), the leader in birth control to manage rodent pest populations, today announces that the New York City Council has approved a bill to implement a rat contraception pilot program. From the bill, the term "rat contraceptive" means an agent for the reduction of reproductive capacity in rats that is approved for such use by the United States Environment Protection Agency. SenesTech is currently the only manufacturer of products that meet this requirement.

2024年10月8日,鳳凰城——SenesTech公司(納斯達克股票代碼:SNES)是管理齧齒害蟲數量控制的避孕領域的領導者,今天宣佈紐約市議會已批准一項法案,實施試行一項鼠類避孕計劃。根據該法案,"鼠類避孕藥"指的是一種經美國環境保護局批准用於在鼠類中減少生育能力的藥物。SenesTech目前是滿足該要求的產品唯一製造商。

big

This bill, Int. No. 736-A, mandates the Department of Health and Mental Hygiene (DOHMH), in collaboration with the Department of Sanitation (DSNY) and a rodent control expert, to launch a pilot program deploying rat contraceptives within 180 days of enactment.

該法案Int. No. 736-A要求衛生與精神衛生部(DOHMH)與衛生局(DSNY)及齧齒控制專家合作,在法案生效180天內推出部署鼠類避孕藥的試點計劃。

The program will run for at least 12 months in two rat mitigation zones and a comparable area, focusing on residential buildings with waste in containers. DOHMH must conduct monthly inspections, tracking rat activity, and report findings to the Mayor and City Council after the pilot period.

該計劃將在兩個鼠類防治區域和一個可比較區域運行至少12個月,重點關注帶有容器內廢物的住宅樓。DOHMH必須進行每月檢查,跟蹤鼠類活動,並在試點期後向市長和市議會彙報研究結果。

"SenesTech has two product lines on the market today, ContraPest and Evolve, that have shown efficacy and safety in deployments throughout the United States and around the globe. We are the provider of Rat Birth Control. We look forward to supporting New York City in their pilot program," said Joel Fruendt, SenesTech's President and CEO.

「SenesTech今天在市場上有兩個產品系列,ContraPest和Evolve,已在美國和全球範圍內的部署中顯示出有效性和安全性。我們是鼠類避孕的提供商。我們期待支持紐約市的試點計劃,」SenesTech的總裁兼首席執行官Joel Fruendt表示。

About SenesTech, Inc.

關於SenesTech公司

We are committed to improving the health of the world by humanely managing animal pest populations through our expertise in fertility control. We are the inventors of Evolve Rat and Evolve Mouse, EPA-designated minimum risk contraceptives for rodents which reflect our mission to provide products that are proactive, safe and sustainable. Evolve fits seamlessly into all integrated pest management programs, significantly improving the overall goal of effective pest management. We strive for clean cities, efficient businesses and happy households – with a product designed to be humane, effective and sustainable.

我們致力於通過控制繁殖來人道地管理動物害蟲數量,我們是Evolve Rat和Evolve Mouse的發明者,這些產品是美國環保署指定的齧齒最低風險避孕藥物,反映了我們提供前瞻、安全和可持續產品的使命。Evolve無縫融入所有綜合害蟲管理計劃,顯着提高了有效害蟲管理的總體目標。我們追求潔淨城市、高效企業和幸福家庭——這款產品旨在人道、高效和可持續。

For more information visit

獲取更多信息,請訪問

Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby. Such forward-looking statements include, among others, our expectation that the New York program will run for at least 12 months in two rat mitigation zones and a comparable area, focusing on residential buildings with waste in containers. Forward-looking statements may describe future expectations, plans, results or strategies and are often, but not always, made through the use of words such as "believe," "may," "future," "plan," "will," "should," "expect," "anticipate," "eventually," "project," "estimate," "continuing," "intend" and similar words or phrases. You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, the successful commercialization of our products, market acceptance of our products, our financial performance, including our ability to fund operations, our ability to maintain compliance with Nasdaq's continued listing requirements, regulatory approval and regulation of our products and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2023. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.

免責聲明
本新聞稿包含了根據聯邦證券法的「前瞻性陳述」,我們打算使這些前瞻性陳述受到相應的安全港保護。這些前瞻性陳述包括但不限於我們預期紐約項目將在兩個鼠害緩解區和一個可比較區域至少運行12個月,重點關注帶有廢物容器的住宅建築。前瞻性陳述可能描述未來的期望、計劃、結果或策略,並通常但不總是通過使用諸如「相信」、「可能」、「未來」、「計劃」、「將」、「應該」、「期望」、「預期」、「最終」、「項目」、「估計」、「持續」、「打算」等詞語。請注意,此類陳述可能受到風險、不確定性和其他因素的影響,這些因素可能導致實際結果與此類前瞻性陳述反映的結果有實質性差異。這些因素包括但不限於成功商業化我們的產品、市場對我們產品的接受、我們的財務表現,包括我們資金運營的能力,我們能否維持符合納斯達克繼續上市要求,我們的產品的監管批准和監管,以及我們不時在美國證券交易委員會的申報中識別的其他因素和風險,包括我們截至2023年12月31日止財年的年度報告Form 10-k中。本新聞稿中包含的所有前瞻性陳述僅代表其發佈之日的表態,基於管理層在該日期對此類陳述的假設和估計。除非法律要求,我們不承擔更新任何前瞻性陳述的公開承諾,無論是因爲收到新信息、未來事件發生或其他原因。

CONTACT:
Investors:
Robert Blum, Joe Dorame, Joe Diaz, Lytham Partners, LLC
602-889-9700, senestech@lythampartners.com

聯繫方式:
投資者:
Robert Blum,Joe Dorame,Joe Diaz,Lytham Partners,LLC
602-889-9700、senestech@lythampartners.com

Media and Marketing Contact:
Rochelle Paulet, Director of Marketing, SenesTech, Inc.
928-779-4143 x814, rochelle.paulet@senestech.com

媒體和營銷聯繫人:
營銷董事Rochelle Paulet,senestech公司。
928-779-4143 分機814, rochelle.paulet@senestech.com

SOURCE SenesTech, Inc.

SOURCE SenesTech,Inc.

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論